Evidence map›Paper›PMID 28196483›Full record

ArticleBMC cardiovascular disorders2017

Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction.

Ilya Karagodin, Omer Aba-Omer, Rodney Sparapani, Jennifer L Strande

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in BMC cardiovascular disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04395846 (Heart Failure and Preserved Ejection Fraction), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04395846 active not recruitingnot on this mapstarted 2020, after this paper: background citation

Heart Failure and Preserved Ejection Fraction: Observation of Its Progression and Prognosis (HOPP-BERN)

TypeobservationalSponsorInsel Gruppe AG, University Hospital BernRan2020 to 2029Enrolled350ConditionsHeart Failure With Preserved Ejection Fraction
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Low and High Pressor Doses of Ang II Lead to Two Distinct Phenotypes of Hypertensive Heart Disease in Mice.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ilya KaragodinDepartment of Medicine, Medical College of Wisconsin, 9200 Wisconsin Ave, Milwaukee, WI, 53226, USA. ikaragodin@mcw.edu.ORCID 0000-0001-9483-2155
Omer Aba-OmerDepartment of Medicine, Medical College of Wisconsin, 9200 Wisconsin Ave, Milwaukee, WI, 53226, USA.
Rodney SparapaniDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
Jennifer L StrandeDepartment of Medicine, Medical College of Wisconsin, 9200 Wisconsin Ave, Milwaukee, WI, 53226, USA.

Funding

Clinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5M
Clincal and Translational Science AwardUL1TR000055 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI SHAKER, REZA NONE · 2012 to 2015
$11.3M
iPSC-derived cardiomyocytes to study dystrophic cardiomyopathyK08HL111148 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI STRANDE, JENNIFER LYNN · 2012 to 2016
$670k
NCATS NIH HHS UL1 TR000055NCATS NIH HHS UL1 TR001436NHLBI NIH HHS K08 HL111148
6 · The paper itself

Abstract

backgroundIdentifying which patients with diastolic dysfunction will progress to heart failure with preserved ejection fraction (HFpEF) remains challenging. The goal of this study is to determine whether increased vascular stiffness as identified on 2D transthoracic echocardiography (TTE) serves as a biomarker for the development of HFpEF in patients with diastolic dysfunction.

methodsThe study design is a matched retrospective case-control study. Subjects with diastolic dysfunction were divided into two groups based on whether they had a clinical diagnosis of HFpEF. The two groups were matched based on age, gender, race and body surface area, resulting in 77 matched pairs (n = 154). Data from the first TTE that documented diastolic dysfunction prior to the development of HFpEF was extracted along with baseline demographic and clinical data. Indices of vascular stiffness were measured and compared. A sub-group analysis was performed to compare diabetic subjects in Group 1 (n = 43) to those in Group 2 (n = 21).

resultsGroup 1 had significantly decreased aortic distensibility as measured on the initial TTE when compared to Group 2 (1.9 ± 1.0 vs. 2.8 ± 1.8 cm

conclusionsThis study demonstrates that increased proximal aortic stiffness is associated with the development of HFpEF in patients with asymptomatic diastolic dysfunction. Larger prospective studies are needed to further investigate this relationship.

Indexed as

Asymptomatic DiseasesAgedAortaDiastoleDisease ProgressionEchocardiographyFemaleFollow-Up StudiesHeart FailureHumansMalePrognosisRetrospective StudiesStroke VolumeTime FactorsVascular StiffnessBiomarkerCardiomyopathyDiabetesEchocardiographyHeart FailureHeart Failure with Preserved Ejection Fraction (HFpEF)

Identifiers

PMID28196483
PMCPMC5310057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.